In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Valeant pays $A625mm up front and $A75mm in earn-outs for iNova

Executive Summary

In its latest takeover to increase international exposure, serial acquirer Valeant Pharmaceuticals International Inc. has paid $A625mm ($625mm) up front for privately held Australian company iNova Pharmaceuticals Pty. Ltd. (prescription and OTC drugs), which is also entitled to $A75mm in earn-outs tied to pipeline progress, product registrations, and revenues.
Deal Industry
  • Pharmaceuticals
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Cash
    • Full Acquisition
    • Includes Earnout

Related Companies

Advertisement
UsernamePublicRestriction

Register